))
LARVOL Onco Data Podcast: Post-World Lung Analysis with Christian Hayden from Opus Strategy | E.29
Manage episode 444078351 series 3606267
Innhold levert av Bruno Larvol, Mark Gramling, Bruno Larvol, and Mark Gramling. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Bruno Larvol, Mark Gramling, Bruno Larvol, and Mark Gramling eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Join us for an episode of the LARVOL Onco Data Podcast where Mark Gramling, VP of Oncology at LARVOL, hosts Christian Hayden from Opus Strategy for a Post-World Lung Cancer Conference (WCLC) analysis. Mark and Christian dive into key discussions surrounding emerging oncology targets and reflect on the recent Tropion trial’s ups and downs. They provide valuable insights into the latest data, exploring the landscape of new targets and therapies in different markets and geographies. 💡 Key Topics Discussed: • Reflections on the Tropion trial and its implications in oncology • Analyzing new targets and their impact across various geographies Don’t miss this conversation about the nuances of oncology data and strategy. For more on strategic consulting in the pharma space, reach out to Christian Hayden at Opus Strategy. For oncology data support, LARVOL is here to assist. #Oncology #LARVOL #WCLC #ClinicalTrials
32 episoder
Del
